Revance price target raised to $9 from $8 at Goldman Sachs

Goldman Sachs raised the firm’s price target on Revance to $9 from $8 and keeps a Neutral rating on the shares. The company’s Q4 results were in line with expectations, revealing account growth, with about 3,000 out of the 7,000 aggregate Revance accounts ordering Daxxify and overall account growth increasing from 5,000 at 2022-end, the analyst tells investors in a research note.